News tagged with monoclonal antibodies
Rituximab possible treatment option for patients with primary biliary cirrhosis
An open-label study of rituximab, a monoclonal antibody for human CD20, was shown to be safe in patients with primary biliary cirrhosis (PBC) who had an incomplete response to the standard ursodeoxycholic acid (UDCA) therapy, ...
Feb 02, 2012 |
not rated yet |
0
Study identifies a cause of resistance to colon cancer treatment
Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal ...
Jan 22, 2012 |
5 / 5 (1) |
0
A new way to stimulate the immune system and fight infection
A study carried out by Eric Vivier and Sophie Ugolini at the Marseille-Luminy Centre for Immunology has just reveal a gene in mice which, when mutated, can stimulate the immune system to help fight against tumors and viral ...
Jan 20, 2012 |
5 / 5 (3) |
0
RTOG initiates a phase I trial testing the therapy ganitumab for locally advanced pancreatic cancer
Over 17,000 patients will have been diagnosed with locally-advanced pancreatic cancer in the United States in 2011. Surgery is not a treatment option for these patients whose tumor has grown beyond the pancreas to surrounding ...
Dec 14, 2011 |
5 / 5 (2) |
0
More intensive chemotherapy dramatically improves recurrence, survival in younger patients with aggressive lymphoma
Younger patients with diffuse large B-cell lymphoma given a more intensive regimen of chemotherapy combined with rituximab survive significantly longer, and are approximately twice as likely to remain in remission 3 years ...
Nov 24, 2011 |
not rated yet |
0
New treatment for Multiple Sclerosis: Cambridge University translates research at the bench into a drug at the bedside
The culmination of three decades of research in Cambridge has resulted in the exciting prospect of a new transformational treatment for multiple sclerosis.
Nov 15, 2011 |
not rated yet |
0
Injection lowers cholesterol in preliminary human trial
Patients unable to control their cholesterol levels with medications may someday be able to lower their "bad" cholesterol with a shot, according to research presented at the American Heart Association's Scientific Sessions ...
Medicine & Health / Cardiology
Nov 14, 2011 |
2.3 / 5 (3) |
2
Combination therapy shows potent tumor growth inhibition in preclinical studies
Combining the investigational agents REGN910 and aflibercept yielded statistically significant improvements in antitumor effects in animal models compared with either agent alone, according to results presented at the AACR-NCI-EORTC ...
Nov 13, 2011 |
not rated yet |
0
New target identified to stop the spread of breast cancer
A new potential target to slow breast cancer tumor progression and metastasis has been identified by a team of researchers led by Dr. Richard Kremer from the Research Institute of the McGill University Health Centre (RI-MUHC). ...
Nov 10, 2011 |
5 / 5 (1) |
0
Experimental drug suppresses rebound of hepatitis C virus in liver transplant patients
A human monoclonal antibody developed by MassBiologics of the University of Massachusetts Medical School (UMMS) given to patients with chronic hepatitis C virus (HCV) infection undergoing liver transplantation significantly ...
Nov 07, 2011 |
not rated yet |
0
New findings may help explain high blood pressure in pregnancy
Virginia Commonwealth University School of Medicine researchers have discovered that the infiltration of white blood cells into an expectant mother's blood vessels may explain high blood pressure in pregnancy.
Oct 31, 2011 |
not rated yet |
0
|
Major advance in the treatment of Hendra virus reported
A collaborative research team from Boston University School of Medicine (BUSM), the Uniformed Services University of the Health Sciences (USU), the University of Texas Medical Branch (UTMB) and Galveston National ...
Oct 19, 2011 |
5 / 5 (1) |
0
|
Biological agents for rheumatoid arthritis associated with increased skin cancer risk
Biological agents used to treat rheumatoid arthritis seem to be associated with an increased risk of skin cancer, indicates a systematic review of published research in the Annals of the Rheumatic Diseases.
Sep 08, 2011 |
3 / 5 (2) |
0
Humabs discovers the first antibody to neutralize both group 1 and group 2 influenza A viruses
A paper published today in the scientific research journal Science, describes a novel, proprietary monoclonal antibody (FI6) discovered in a collaboration between Humabs BioMed SA, the Institute for Research in Biomedicine ("IRB" ...
Jul 28, 2011 |
5 / 5 (1) |
0
|
Clinical tests for medicines made from genetically modified plants
UK regulators have approved Europe's first clinical trial of a monoclonal antibody produced from genetically modified plants. This landmark decision sets the stage for the testing, in humans, of an anti-HIV product made from ...
Jul 21, 2011 |
not rated yet |
0
Monoclonal antibodies
Monoclonal antibodies (mAb or moAb) are monospecific antibodies that are identical because they are produced by one type of immune cell that are all clones of a single parent cell. Given almost any substance, it is possible to create monoclonal antibodies that specifically bind to that substance; they can then serve to detect or purify that substance. This has become an important tool in biochemistry, molecular biology and medicine. When used as medications, the generic drug name ends in -mab (see "Nomenclature of monoclonal antibodies").
For more information about Monoclonal antibodies, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
